Due to the difficulty of intraocular fluid sampling and the limitation of sample size, the application of various traditional experimental diagnostic techniques in ophthalmology is hindered. At present, anterior chamber puncture, vitreous cavity puncture and drainage as well as vitrectomy are main methods in use to obtain specimens for intraocular examination.


With the development of experimental diagnostic technology and the emergence of high sensitivity and high throughput molecular diagnostic technology, the detection techniques of micro-intraocular fluid samples has made considerable progress. Multi-bead immunoassay, protein and gene chip, proteomics technology, the second and third generation high-throughput sequencing technology have made the high-throughput and high-sensitivity detection of micro-samples come true.


The samples of aqueous humor and other intraocular fluids collected using our devices based on the principle of anterior chamber puncture sampling are already able to satisfy the multiple detection techniques above. At the same time, the combination of IVD reagent and networked detection and diagnostic devices developed by our company will greatly improve the effectiveness and accuracy of precise diagnosis and treatment in ophthalmology.


受眼内液体取样困难和标本量的限制,各种传统实验诊断技术在眼科领域应用受到一定的阻碍。目前眼内检测标本的获取方式主要是前房穿刺术、玻璃体腔穿刺抽液术以及玻璃体切割术。

随着实验诊断技术的发展以及高敏感度、高通量分子诊断技术的出现,微量眼内液标本的诊断性检测技术取得长足的进步。多重微珠免疫分析法、蛋白和基因芯片、蛋白质组学技术、第二代和第三代高通量测序技术等已经实现了微量标本的高通量、高灵敏度检测

公司基于前房穿刺采样原理所采集的房水眼内液标本已能够满足以上多种检测技术同时基于自研生产开发的IVD试剂与联网式的检测诊断仪器的配套应用,大大提升眼科精准诊断与治疗方案的有效性与精准性。